Grupo para la caracterización molecular de las neoplasias hematológicas
University of Chicago
Chicago, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Chicago (4)
2022
-
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
New England Journal of Medicine, Vol. 386, Núm. 7, pp. 629-639
2016
-
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Cancer, Vol. 122, Núm. 14, pp. 2178-2185
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557